Dr. Stern leads an NIH funded research program focused on understanding the role of glucoregulatory hormone signaling in the pathogenesis of obesity, type II diabetes mellitus, and aging. The goal of Stern lab research is to improve the prevention and treatment of diabetes and age-related metabolic disorders.